CCL2 and neoplasm: Normally, neutrophils respond to tissue damage and defend against pathogens (36), but in the TME, tumor-associated neutrophils or PMN-MDSCs express various cytokines, including CCL2 and CCL17, depending on their immunosuppressive or immune-activating state, and can degranulate to release various types of bioactive molecules (37, 38).